FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to cardiology. In order to predict post-infarction remodeling of left ventricle (LV) myocardium in patients with myocardial infarction (MI) laboratory blood parameters in said category of patients are analysed. In particular, estimated are levels of N-terminal brain natriuretic peptide precursor (NTproBNP), pg/ml, matrix metalproteinase 9 (MMP9), ng/ml, highly-sensitive C-reactive protein (hs CRP), mg/l, metalproteinase 1 precursor (proMMPI), ng/l and content, %. All parameters are analysed on 3-5 day of disease and remodeling of LV myocardium in patients with MI is predicted by formula: K=0.009×MMP9+0.00032×NTproBNP+0.15×m+0.03×proMMPI+0.08×hsCRP-5.4, where K is prognostic index of post-infarction remodeling of LV myocardium. If value K>-0.85, high risk of post-infarction remodelling of LV myocardium in patients with MI is predicted.
EFFECT: method increases accuracy of prediction of post-infarction remodelling of LV myocardium in patients with MI after three months after disease beginning due to correlation analysis between levels of MMP9, proMMPl, hsCRP, NTproBNP and monocytes.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE PROBABILITY OF DEVELOPING UNFAVORABLE HEART LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2021 |
|
RU2770285C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVORABLE REMODELING OF THE LEFT VENTRICLE OF THE HEART IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION WITH ST STENT ELEVATION WITHIN 6 MONTHS OF THE ONSET OF THE DISEASE | 2017 |
|
RU2662093C1 |
METHOD FOR PREDICTION OF PURULENT-SEPTIC RHINOSINUSOGENIC COMPLICATIONS OF ORBIT AND EYELIDS IN INFLAMMATORY PARANASAL SINUS INFECTIONS IN CHILDREN | 2020 |
|
RU2732527C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR REMODELING AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND HEART FAILURE USING A MULTIVARIATE REGRESSION MODEL | 2022 |
|
RU2806237C1 |
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITH ISCHEMIC AND/OR POSTINFARCTION MYOCARDIAL DYSFUNCTION ACCOMPANYING CHRONIC CARDIAL INSUFFICIENCY | 2014 |
|
RU2568577C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
METHOD OF TREATMENT OF MYOCARDIAL FIBROSIS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2022 |
|
RU2802996C1 |
METHOD OF DISEASE OUTCOME PREDICTION IN ELDERLY AND OLD PATIENTS SUFFERING FROM CARDIAC INSUFFICIENCY | 2007 |
|
RU2353933C1 |
METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2018 |
|
RU2716479C1 |
Authors
Dates
2012-10-27—Published
2011-07-11—Filed